Your browser doesn't support javascript.
loading
IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
Halvorsen, Bente; Viermyr, Hans-Kittil; Ueland, Thor; Sagen, Ellen L; Michelsen, Annika E; Bjerkeli, Vigdis; Tveita, Anders A; Henriksen, Katerina N; Kåsine, Trine; Dyrhol-Riise, Anne Ma; Trøseid, Marius; Dahl, Tuva B; Aukrust, Pål; Gregersen, Ida.
Afiliação
  • Halvorsen B; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
  • Viermyr HK; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway.
  • Ueland T; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, Tro
  • Sagen EL; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway.
  • Michelsen AE; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
  • Bjerkeli V; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway.
  • Tveita AA; Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, 1346 Gjettum, Norway; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.
  • Henriksen KN; Department of Hematology, Oslo University Hospital, Oslo, Norway; Hospital Pharmacies, South-Eastern Norway Enterprise, Oslo, Norway.
  • Kåsine T; Department of Anaesthesia and Intensive Care Medicine, Oslo University Hospital, Oslo, Norway.
  • Dyrhol-Riise AM; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Department of Infectious Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Trøseid M; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Dahl TB; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  • Aukrust P; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Gregersen I; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway. Electronic address: ida.gregersen@medisin.uio.no.
J Infect ; 89(1): 106176, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38719108
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucinas / SARS-CoV-2 / COVID-19 / Interleucina 22 / Hospitalização Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucinas / SARS-CoV-2 / COVID-19 / Interleucina 22 / Hospitalização Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article